交銀國際(03329.HK):股權投資激活新動能 欲加速佈局新興產業
近年來,交銀國際(03329.HK)積極服務戰略性新興產業高質量發展,充分發揮交銀集團投行業務平台優勢,以股權投資為抓手,以交銀科創基金為引領,為優質科創企業提供全生命週期的“融資+融智”服務。
據瞭解,交銀國際作為投資方參與了孚能科技(贛州)股份有限公司(“孚能科技”)、康方生物科技(開曼)有限公司(“康方生物”)兩家企業的股權投資,目前孚能科技獲上交所科創板股票上市委員會審議通過,成為科創板動力電池第一股,康方生物通過港交所上市聆訊,有望成為今年第二家在港上市的未盈利生物科技公司,交銀國際同時還擔任康方生物上市項目聯繫全球協調人。除此之外,交銀國際參與股權投資企業中還有3家擬申報科創板上市。
為聚焦服務長三角一體化發展和科創板建設,2019年4月,交銀國際在上海發起設立交銀科創股權投資基金,成為中國首支銀行系科創類股權投資基金。交銀國際擔任基金管理人,匯聚交銀集團資源對接科創板。截至目前,科創基金投資涵蓋雲計算、大數據、生物醫藥、人工智能等科創板重點支持行業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.